Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 35 studies | 34% ± 14% | |
macrophage | 24 studies | 27% ± 13% | |
classical monocyte | 23 studies | 47% ± 19% | |
pericyte | 22 studies | 37% ± 15% | |
smooth muscle cell | 20 studies | 39% ± 13% | |
monocyte | 18 studies | 31% ± 15% | |
connective tissue cell | 12 studies | 26% ± 13% | |
endothelial cell | 11 studies | 22% ± 5% | |
myofibroblast cell | 11 studies | 31% ± 8% | |
platelet | 10 studies | 33% ± 14% | |
conventional dendritic cell | 8 studies | 20% ± 6% | |
non-classical monocyte | 8 studies | 36% ± 13% | |
alveolar macrophage | 7 studies | 34% ± 8% | |
myeloid cell | 7 studies | 28% ± 8% | |
megakaryocyte | 6 studies | 62% ± 22% | |
intermediate monocyte | 6 studies | 41% ± 19% | |
endothelial cell of vascular tree | 6 studies | 27% ± 16% | |
dendritic cell | 5 studies | 30% ± 5% | |
ionocyte | 5 studies | 48% ± 11% | |
neutrophil | 5 studies | 37% ± 20% | |
epithelial cell | 5 studies | 24% ± 6% | |
adventitial cell | 5 studies | 36% ± 14% | |
basal cell | 5 studies | 28% ± 15% | |
luminal cell of prostate epithelium | 4 studies | 19% ± 3% | |
adipocyte | 4 studies | 33% ± 24% | |
mononuclear phagocyte | 3 studies | 39% ± 4% | |
chondrocyte | 3 studies | 33% ± 2% | |
endothelial cell of artery | 3 studies | 24% ± 1% | |
inflammatory macrophage | 3 studies | 27% ± 12% | |
vein endothelial cell | 3 studies | 17% ± 0% | |
mast cell | 3 studies | 21% ± 2% | |
myoepithelial cell | 3 studies | 34% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 95% | 35810.34 | 436 / 459 | 97% | 241.33 | 1088 / 1118 |
lung | 99% | 105023.64 | 570 / 578 | 89% | 116.59 | 1030 / 1155 |
intestine | 81% | 44366.82 | 783 / 966 | 85% | 104.88 | 449 / 527 |
bladder | 76% | 32427.95 | 16 / 21 | 78% | 99.92 | 394 / 504 |
esophagus | 62% | 24152.74 | 893 / 1445 | 90% | 140.42 | 165 / 183 |
stomach | 58% | 45200.64 | 210 / 359 | 92% | 127.48 | 263 / 286 |
ovary | 80% | 25889.38 | 144 / 180 | 65% | 57.58 | 278 / 430 |
uterus | 86% | 41110.06 | 147 / 170 | 55% | 63.08 | 251 / 459 |
prostate | 70% | 21865.99 | 172 / 245 | 70% | 66.83 | 350 / 502 |
kidney | 55% | 15084.69 | 49 / 89 | 78% | 128.10 | 707 / 901 |
pancreas | 22% | 3372.37 | 71 / 328 | 92% | 210.28 | 164 / 178 |
skin | 63% | 94255.83 | 1140 / 1809 | 49% | 44.91 | 231 / 472 |
adipose | 89% | 65945.76 | 1076 / 1204 | 0% | 0 | 0 / 0 |
adrenal gland | 64% | 14485.72 | 164 / 258 | 25% | 26.84 | 57 / 230 |
blood vessel | 84% | 30598.92 | 1120 / 1335 | 0% | 0 | 0 / 0 |
thymus | 49% | 10847.13 | 318 / 653 | 35% | 23.87 | 209 / 605 |
spleen | 72% | 16711.80 | 173 / 241 | 0% | 0 | 0 / 0 |
liver | 28% | 6493.19 | 64 / 226 | 37% | 32.21 | 150 / 406 |
tonsil | 0% | 0 | 0 / 0 | 60% | 37.70 | 27 / 45 |
heart | 54% | 18100.19 | 463 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 28% | 8211.34 | 259 / 929 | 0% | 0 | 0 / 0 |
brain | 0% | 27.03 | 5 / 2642 | 11% | 10.79 | 77 / 705 |
muscle | 8% | 1246.07 | 62 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 7% | 3.85 | 2 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0033574 | Biological process | response to testosterone |
GO_0006986 | Biological process | response to unfolded protein |
GO_2001027 | Biological process | negative regulation of endothelial cell chemotaxis |
GO_0006954 | Biological process | inflammatory response |
GO_0051895 | Biological process | negative regulation of focal adhesion assembly |
GO_1902043 | Biological process | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors |
GO_0043537 | Biological process | negative regulation of blood vessel endothelial cell migration |
GO_0006955 | Biological process | immune response |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_2000379 | Biological process | positive regulation of reactive oxygen species metabolic process |
GO_0001666 | Biological process | response to hypoxia |
GO_0010751 | Biological process | negative regulation of nitric oxide mediated signal transduction |
GO_0002605 | Biological process | negative regulation of dendritic cell antigen processing and presentation |
GO_0051897 | Biological process | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_0009612 | Biological process | response to mechanical stimulus |
GO_0009410 | Biological process | response to xenobiotic stimulus |
GO_2000353 | Biological process | positive regulation of endothelial cell apoptotic process |
GO_0043652 | Biological process | engulfment of apoptotic cell |
GO_0051592 | Biological process | response to calcium ion |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_0032914 | Biological process | positive regulation of transforming growth factor beta1 production |
GO_0018149 | Biological process | peptide cross-linking |
GO_0010748 | Biological process | negative regulation of long-chain fatty acid import across plasma membrane |
GO_0032026 | Biological process | response to magnesium ion |
GO_0034976 | Biological process | response to endoplasmic reticulum stress |
GO_0045766 | Biological process | positive regulation of angiogenesis |
GO_0038060 | Biological process | nitric oxide-cGMP-mediated signaling |
GO_0051918 | Biological process | negative regulation of fibrinolysis |
GO_0010757 | Biological process | negative regulation of plasminogen activation |
GO_0010763 | Biological process | positive regulation of fibroblast migration |
GO_0001953 | Biological process | negative regulation of cell-matrix adhesion |
GO_0032695 | Biological process | negative regulation of interleukin-12 production |
GO_0007155 | Biological process | cell adhesion |
GO_0043032 | Biological process | positive regulation of macrophage activation |
GO_0001937 | Biological process | negative regulation of endothelial cell proliferation |
GO_0030194 | Biological process | positive regulation of blood coagulation |
GO_0045727 | Biological process | positive regulation of translation |
GO_0032760 | Biological process | positive regulation of tumor necrosis factor production |
GO_0040037 | Biological process | negative regulation of fibroblast growth factor receptor signaling pathway |
GO_0043154 | Biological process | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process |
GO_0042327 | Biological process | positive regulation of phosphorylation |
GO_0090051 | Biological process | negative regulation of cell migration involved in sprouting angiogenesis |
GO_1903588 | Biological process | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis |
GO_0043536 | Biological process | positive regulation of blood vessel endothelial cell migration |
GO_0050921 | Biological process | positive regulation of chemotaxis |
GO_0048661 | Biological process | positive regulation of smooth muscle cell proliferation |
GO_0010754 | Biological process | negative regulation of cGMP-mediated signaling |
GO_0071363 | Biological process | cellular response to growth factor stimulus |
GO_0002040 | Biological process | sprouting angiogenesis |
GO_0043406 | Biological process | positive regulation of MAP kinase activity |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0048266 | Biological process | behavioral response to pain |
GO_0016477 | Biological process | cell migration |
GO_0032570 | Biological process | response to progesterone |
GO_0030511 | Biological process | positive regulation of transforming growth factor beta receptor signaling pathway |
GO_0002544 | Biological process | chronic inflammatory response |
GO_0034605 | Biological process | cellular response to heat |
GO_0009749 | Biological process | response to glucose |
GO_0010595 | Biological process | positive regulation of endothelial cell migration |
GO_1903671 | Biological process | negative regulation of sprouting angiogenesis |
GO_0010759 | Biological process | positive regulation of macrophage chemotaxis |
GO_0016525 | Biological process | negative regulation of angiogenesis |
GO_0071356 | Biological process | cellular response to tumor necrosis factor |
GO_0002581 | Biological process | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II |
GO_0030335 | Biological process | positive regulation of cell migration |
GO_2001237 | Biological process | negative regulation of extrinsic apoptotic signaling pathway |
GO_0006915 | Biological process | apoptotic process |
GO_0010596 | Biological process | negative regulation of endothelial cell migration |
GO_0009986 | Cellular component | cell surface |
GO_0005788 | Cellular component | endoplasmic reticulum lumen |
GO_0005577 | Cellular component | fibrinogen complex |
GO_0031091 | Cellular component | platelet alpha granule |
GO_0005576 | Cellular component | extracellular region |
GO_0070062 | Cellular component | extracellular exosome |
GO_0031093 | Cellular component | platelet alpha granule lumen |
GO_0005615 | Cellular component | extracellular space |
GO_0009897 | Cellular component | external side of plasma membrane |
GO_0031012 | Cellular component | extracellular matrix |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0016529 | Cellular component | sarcoplasmic reticulum |
GO_0030141 | Cellular component | secretory granule |
GO_0062023 | Cellular component | collagen-containing extracellular matrix |
GO_0005201 | Molecular function | extracellular matrix structural constituent |
GO_0005509 | Molecular function | calcium ion binding |
GO_0070051 | Molecular function | fibrinogen binding |
GO_0004866 | Molecular function | endopeptidase inhibitor activity |
GO_0050431 | Molecular function | transforming growth factor beta binding |
GO_0043236 | Molecular function | laminin binding |
GO_0043394 | Molecular function | proteoglycan binding |
GO_0008201 | Molecular function | heparin binding |
GO_0001786 | Molecular function | phosphatidylserine binding |
GO_0001968 | Molecular function | fibronectin binding |
GO_0002020 | Molecular function | protease binding |
GO_0030169 | Molecular function | low-density lipoprotein particle binding |
GO_0005515 | Molecular function | protein binding |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0005178 | Molecular function | integrin binding |
GO_0070052 | Molecular function | collagen V binding |
GO_0017134 | Molecular function | fibroblast growth factor binding |
Gene name | THBS1 |
Protein name | Thrombospondin-1 (Glycoprotein G) Thrombospondin 1 THBS1 protein |
Synonyms | TSP1 TSP |
Description | FUNCTION: Adhesive glycoprotein that mediates cell-to-cell and cell-to-matrix interactions . Multifunctional, involved in inflammation, angiogenesis, wound healing, reactive oxygen species (ROS) signaling, nitrous oxide (NO) signaling, apoptosis, senescence, aging, cellular self-renewal, stemness, and cardiovascular and metabolic homeostasis . Negatively modulates dendritic cell activation and cytokine release, as part of an autocrine feedback loop, contributing to the resolution of inflammation and immune homeostasis . Ligand for receptor CD47 . Modulates nitrous oxide (NO) signaling via CD47, hence playing a role as a pressor agent, supporting blood pressure (By similarity). Plays a role in endothelial cell senescence, acting via CD47, by increasing the abundance and activation of NADPH oxidase NOX1, and so generating excess ROS . Inhibits stem cell self-renewal, acting via CD47 signaling, probably by regulation of the stem cell transcription factors POU5F1/OCT4, SOX2, MYC/c-Myc and KLF4 (By similarity). Negatively modulates wound healing, acting via CD47 (By similarity). Ligand for receptor CD36 . Involved in inducing apoptosis in podocytes in response to elevated free fatty acids, acting via CD36 (By similarity). Plays a role in suppressing angiogenesis, acting, depending on context, via CD36 or CD47 . Promotes cellular senescence in a TP53-CDKN1A-RB1 signaling-dependent manner . Ligand for immunoglobulin-like cell surface receptor SIRPA . Involved in ROS signaling in non-phagocytic cells, stimulating NADPH oxidase-derived ROS production, acting via interaction with SIRPA . Plays a role in metabolic dysfunction in diet-induced obesity, perhaps acting by exacerbating adipose inflammatory activity; its effects may be mediated, at least in part, through enhanced adipocyte proliferation (By similarity). Plays a role in ER stress response, via its interaction with the activating transcription factor 6 alpha (ATF6) which produces adaptive ER stress response factors (By similarity). May be involved in age-related conditions, including metabolic dysregulation, during normal aging . . |
Accessions | P07996 ENST00000260356.6 [P07996-1] ENST00000397591.2 A8MZG1 A0A0B6XK25 A0PJG0 |